Novartis And Qualcomm Partner In mHealth
The companies are partnering to invest in start-ups that have the potential to change health care delivery and are using Qualcomm’s 2net Platform in a clinical trial to aggregate patient data and personalize treatments.
You may also be interested in...
The swapping of product portfolios with other companies remains on track at Switzerland’s big pharma Novartis, despite a seven-percentage-point sales erosion due to emerging generic competition during 2014, and more recent currency turmoil in its home country.
Companies developing new digital health technologies say that the US health system needs to upgrade and start adopting tools that can track patients beyond hospital walls. Qualcomm Life aims to assist by merging data into information that health care providers can actually use.
Nidda Healthcare, the investment vehicle controlled by Bain Capital and Cinven, has decided on a share price for the final squeeze-out of Stada’s remaining minority shareholders.